This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Zach System. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Elisenda Trepat Guixer
Introduction
Elisenda Trepat Guixer is a notable inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of olopatadine, a medication used to treat allergic conditions. Her work exemplifies the intersection of innovation and practical application in the medical field.
Latest Patents
Elisenda holds a patent for a process for preparing olopatadine and/or a pharmaceutically acceptable salt thereof. The patent details an improved method of synthesizing olopatadine, which involves reacting a dibenz[b,e]oxepin-11-one derivative with a suitable reagent under Witting conditions. This innovative approach enhances the efficiency of producing olopatadine and its derivatives, contributing to advancements in pharmaceutical manufacturing.
Career Highlights
Throughout her career, Elisenda has demonstrated a commitment to research and development in the pharmaceutical industry. Her work at Zach System S.p.a. has positioned her as a key player in the field, where she continues to explore new methodologies and processes that can lead to better therapeutic options for patients.
Collaborations
Elisenda has collaborated with esteemed colleagues such as Alberto Guidi and Filippo Chiarello. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and innovations.
Conclusion
Elisenda Trepat Guixer's contributions to the field of pharmaceuticals through her innovative patent and collaborative efforts highlight her role as a significant inventor. Her work not only advances scientific knowledge but also has practical implications for improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile